¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦19ȸ °©»ó¼±¿¬¼öȸ : 2023-07-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦19ȸ °©»ó¼±¿¬¼öȸ : 2023-07-01
±³À°ÀÏÀÚ : 2023-07-01
±³À°Àå¼Ò : ÇѾç´ëÇб³ HITºôµù 6Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : Á¦19ȸ °©»ó¼±¿¬¼öȸ

ÁÖÃÖ±â°ü : ´ëÇѵΰæºÎ¿Ü°úÇÐȸ
´ã´çÀÚ : À̽¾Æ
¿¬¶ôó : 070-4108-7957  

À̸ÞÀÏ : ksthns1990@gmail.com

±³À°Á¾·ù : À̺ñÀÎÈÄ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í Àü¹®ÀÇ 5¸¸¿ø/Àü°øÀÇ ¹× ±âŸ 3¸¸¿ø (ÇöÀåµî·Ï 1¸¸¿ø Ãß°¡)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 08:00~08:20 Registration ( )

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 08:20~08:25 Opening Remark Å°æ(ÇѾçÀÇ´ë)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 08:25~08:30 Congratulatory Remark Á¶±¤Àç(´ëÇѵΰæºÎ¿Ü°úÇÐȸ ȸÀå)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 08:30~09:35 session 1 ±Ç¼ø¿µ ±èµ¿¿µ(°í·ÁÀÇ´ë °¡ÃµÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 08:30~08:45 Genetics of Thyroid Cancer and Molecular Diagnostics À̵¿Áø(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 08:45~09:05 WHO Classification of Thyroid Tumor: 2022 Update ¸íÀç°æ(ÇѾçÀÇ´ë º´¸®°ú)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 09:05~09:20 US in DTC: Pre-Operative Diagnosis and Post-Operative Follow-Up ¾Èµ¿ºó(°æºÏÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 09:20~09:35 RF and Ethanol ablation of Thyroid Tumors Á¶¿ìÁø(À§µå½ÉÀÇ¿ø)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 09:35~10:30 session 2 ¹Ú¿µÇÐ Á¶±¤Àç(°¡Å縯ÀÇ´ë °¡Å縯ÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 09:35~09:50 Screening for Thyroid Cancer: Recommendation and Evidence ±èÇѼö(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 09:50~10:10 Treatment Strategy for Low-Risk PTC ±¸º»¼®(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 10:10~10:30 Optimal Extent of Thyroidectomy: Total vs. Lobectomy vs. Partial Á¤¿µÈ£(¿ï»êÀÇ´ë)

ÈÞ½Ä 07¿ù 01ÀÏ ´ë°­´ç 10:30~10:45 Coffee Break ( )

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 10:45~12:00 session 3 ¼±µ¿ÀÏ ¼Û½Ã¿¬(°¡Å縯ÀÇ´ë ¿µ³²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 10:45~11:05 Management of Central and Lateral Neck LN Metastasis Áö¿ë¹è(ÇѾçÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 11:05~11:20 Management of Follicular Neoplasm and Carcinoma À̼¼¿µ(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 11:20~11:40 Role of RAI Ablation: When and How? À̼öÁø(ÇѾçÀÇ´ë ÇÙÀÇÇаú)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 11:40~12:00 Remote Access Thyroidectomy: Updates on Transoral Thyroidectomy ¹ÚÁØ¿í(°¡Å縯ÀÇ´ë)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 12:00~12:30 session 4. Special Lecture Á¤±¤À±(°í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 12:00~12:30 High-Quality IONM in Thyroid Surgery Feng-Yu Chiang(Taiwan)

½Ä»ç 07¿ù 01ÀÏ ´ë°­´ç 12:30~13:20 lunch ( )

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 13:20~14:40 session 5. Panel Discussion:  Avoiding and Management of Complications in Thyroid Surgery ÀÌ°­´ë ¼ÕÁøÈ£(°í½ÅÀÇ´ë °æºÏÀÇ´ë)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 13:20~14:40 Parathyroid Preservation and Auto-Fluorescence, ICG Angiography, IONM (Conventional and Remote Access Approach), Preservation of EBSLN and RLN and Management of its Invasion, Hematoma, Chyle Leakage, Etc. ( )

Åä·Ð 07¿ù 01ÀÏ ´ë°­´ç 13:20~14:40 Panelists Feng-Yu Chiang ¿Ü 7¸í(Taiwan ¿Ü 7°÷)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 14:40~15:45 session 6 Á¤ÇÊ»ó ¿ìÁ¤¼ö(´Ü±¹ÀÇ´ë °í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 14:40~14:55 Postoperative Management: Tg Elevation and TSH Suppression ·ùÁؼ±(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 14:55~15:10 Management of the Aerodigestive Tract Invasion Á¤ÀºÀç(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 15:10~15:25 Updates on the Management of Anaplastic Carcinoma ¹é½Â±¹(°í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 01ÀÏ ´ë°­´ç 15:25~15:45 Systemic Therapy for Metastatic and Refractory Thyroid Cancer Á¤Çö¾Ö(¼º±Õ°üÀÇ´ë Á¾¾ç³»°ú)

ÈÞ½Ä 07¿ù 01ÀÏ ´ë°­´ç 15:45~16:00 coffee break ( )

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 16:00~17:30 session 7. Panel Discussion: Multidisplinary thyroid cancer tumor board Å°æ(ÇѾçÀÇ´ë)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 16:00~17:30 Case presentor Àº¿µ±Ô ¹ÚÁ¤Á¦ ¿À°æÈ£(°æÈñÀÇ´ë °æ»óÀÇ´ë °í·ÁÀÇ´ë)

Åä·Ð 07¿ù 01ÀÏ ´ë°­´ç 16:00~17:30 Panelist ÀÌ°­´ë 7¸í(°í½ÅÀÇ´ë ¿Ü7°÷)

±âŸ 07¿ù 01ÀÏ ´ë°­´ç 17:30~17:40 Closing remark Å°æ(ÇѾçÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦19ȸ °©»ó¼±¿¬¼öȸ : 2023-07-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ÀÏÂ÷ÀÇ·á ¸¸¼ºÁúȯ °ü¸®»ç¾÷ Àǻ米À° 1ÀÏÂ÷ : 2023-07-01
´ÙÀ½±Û 2023³â ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á ½ÉÆ÷Áö¾ö : 2023-07-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
435 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ The 17th Postgraduate Course of Diabetes : 2018-09-15 0 845 2018-08-15
434 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-15 0 876 2018-08-15
433 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-14 0 962 2018-08-15
432 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 3ÀÏÂ÷ : 2018-09-14 0 2,504 2018-08-15
431 °æ³² ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ¿µ³²ÁöºÎ 2018³â 9¿ù Áý´ãȸ : 2018-09-14 0 952 2018-08-15
430 °æ±â ±¹¸³¾Ï¼¾ÅÍ 2018³â 3Â÷ ÀÇ»ý¸í°úÇÐÆ÷·³ : 2018-09-14 0 765 2018-08-15
429 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø °³¿øÀÇ ¿¬¼ö±³À° : 2018-09-14 0 627 2018-08-15
428 ÃæºÏ Á¦11Â÷ ´ëÇÑÁßÀçÇ÷°ü¿Ü°úÇÐȸ ½ÉÆ÷Áö¾ö : 2018-09-14 0 1,479 2018-08-15
427 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 2ÀÏÂ÷ : 2018-09-13 0 1,542 2018-08-15
426 ¼­¿ï ÀÎÁ¦´ëÇб³»ó°è¹éº´¿ø À̺ñÀÎÈÄ°ú Áý´ãȸ : 2018-09-11 0 507 2018-08-15
425 °æ±â ÇѾç´ëÇб³±¸¸®º´¿ø °©»ó¼± Á¾¾çÀÇ Áø´Ü°ú Ä¡·á: Ãֽŵ¿Çâ : 2018-09-11 0 453 2018-08-15
424 ºÎ»ê Á¦493Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2018-09-10 0 500 2018-08-15
423 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 12ȸ °¡Å縯¼ºÇü½ÉÆ÷Áö¾ö : 2018-09-09 0 788 2018-08-15
422 ¼­¿ï Á߾Ӵ뺴¿ø È£Èí±â¾Ë·¹¸£±â³»°ú ¿¬¼ö°­Á : 2018-09-09 1 775 2018-08-15
421 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ Ç׳ëÈ­¼ºÇü¿¬±¸È¸ Á¦4ȸ ½ÉÆ÷Áö¾ö : 2018-09-09 0 805 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷